ALYCIA DEGEN focuses on the defense of class actions, product liability and mass tort litigation and complex civil and appellate litigation in federal and state courts. Alycia leverages the appropriate experience throughout Sidley to find creative, cost-effective solutions to difficult legal issues, particularly in regulated industries. She has substantial experience in the areas of pharmaceuticals, medical devices, over-the-counter drugs and dietary supplements, automobiles and other consumer products and services, as well as defending these companies against consumer fraud and unfair competition class actions and in related government investigations.
Examples of these engagements include:
- Appointed as Defendants’ lead and liaison counsel in California Judicial Council Coordinated Proceedings (JCCPs) involving large product liability and mass tort litigations.
- Service as national and regional counsel to life sciences companies in product liability and consumer fraud litigation involving pharmaceuticals, medical devices and over-the-counter drugs.
- Obtained dismissal, on grounds of federal preemption, of claims against the manufacturer of a premarket approved (PMA) medical device.
- Represented pharmaceutical company in damages phase of a Hatch-Waxman patent infringement lawsuit in which Sidley obtained a $104 million judgment following a three-week bench trial, of which more than $98 million was affirmed on appeal by the Federal Circuit.
Alycia was recommended in The Legal 500 US 2015 and 2016 for Litigation, Product Liability and Mass Tort Defense. Her cases and victories have been reported in The National Law Journal, Law360 and the Drug and Device Law blog, among others. For example, the federal district court’s judgment in AstraZeneca AB v. Apotex Corp., 985 F. Supp. 2d 452 (S.D.N.Y. 2013), was described in Law360’s article naming the firm number two on its list of Litigation Powerhouses for 2016 and in The National Law Journal’s article naming the firm to its 2014 Intellectual Property Hot List. In addition, the Arkansas Supreme Court’s decision in DePriest v. AstraZeneca Pharms., L.P., 351 S.W.3d 168 (Ark. 2009), was identified as number two on the Drug and Device Law blog’s list of the Top Ten Best Prescription Drug/Medical Device Decisions Of 2009.
Alycia served as law clerk to the Honorable Cynthia Holcomb Hall, United States Court of Appeals for the Ninth Circuit, Pasadena, California and as judicial extern to the Honorable William D. Keller, United States District Court, Los Angeles, California.